Stocks
CME Financial Statements (CME) |
||||||||||
| CMEsmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 25.02.2022 | 31.12.2022 | 27.02.2023 | 31.12.2023 | 28.02.2024 | 01.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 4 690 | 5 019 | 5 019 | 5 579 | 5 579 | 5 854 | |||
| Operating Income, bln rub | 2 645 | 3 016 | 3 016 | 3 436 | 3 436 | 3 646 | ||||
| EBITDA, bln rub | ? | 2 793 | 4 016 | 3 151 | 3 788 | 3 788 | 3 989 | |||
| Net profit, bln rub | ? | 2 636 | 2 691 | 2 691 | 3 186 | 3 226 | 3 319 | |||
| OCF, bln rub | ? | 2 402 | 3 056 | 705.2 | 3 454 | 2 110 | ||||
| CAPEX, bln rub | ? | 127.2 | 89.7 | 0.000 | 76.4 | 40.6 | ||||
| FCF, bln rub | ? | 2 275 | 2 966 | 705.2 | 3 377 | 2 069 | ||||
| Dividend payout, bln rub | 2 189 | 2 634 | 0.000 | 3 236 | 2 729 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 83.0% | 0.00% | 97.9% | 0.00% | 100.3% | 82.2% | ||||
| OPEX, bln rub | 1 208 | 1 250 | 1 250 | 1 105 | 1 105 | 1 155 | ||||
| Cost of production, bln rub | 837.0 | 753.1 | 753.1 | 1 039 | 1 039 | 1 054 | ||||
| R&D, bln rub | 192.6 | 0.000 | 188.6 | 0.000 | 218.7 | 117.9 | ||||
| Interest expenses, bln rub | 166.9 | 162.7 | 162.7 | 159.4 | 159.4 | 159.2 | ||||
| Assets, bln rub | 196 780 | 174 176 | 174 176 | 129 706 | 129 841 | 132 054 | ||||
| Net Assets, bln rub | ? | 27 399 | 26 879 | 26 879 | 26 738 | 26 738 | 27 154 | |||
| Debt, bln rub | 3 445 | 3 438 | 3 438 | 3 425 | 3 884 | 3 426 | ||||
| Cash, bln rub | 2 950 | 2 816 | 2 816 | 3 029 | 3 029 | 1 563 | ||||
| Net debt, bln rub | 495.2 | 622.3 | 622.3 | 396.5 | 855.0 | 1 863 | ||||
| Ordinary share price, rub | 228.5 | 168.2 | 168.2 | 210.6 | 210.6 | 212.5 | ||||
| Number of ordinary shares, mln | 358.3 | 357.8 | 358.7 | 359.5 | 359.0 | 359.3 | ||||
| Market cap, bln rub | 81 866 | 60 162 | 60 321 | 75 711 | 75 610 | 76 353 | ||||
| EV, bln rub | ? | 82 362 | 60 784 | 60 943 | 76 107 | 76 465 | 78 216 | |||
| Book value, bln rub | -3 836 | -4 049 | -4 049 | 16 243 | -3 983 | -3 501 | ||||
| EPS, rub | ? | 7.36 | 7.52 | 7.50 | 8.86 | 8.99 | 9.24 | |||
| FCF/share, rub | 6.35 | 0.00 | 8.27 | 1.96 | 9.41 | 5.76 | ||||
| BV/share, rub | -10.7 | -11.3 | -11.3 | 45.2 | -11.1 | -9.74 | ||||
| EBITDA margin, % | ? | 59.6% | 80.0% | 62.8% | 67.9% | 67.9% | 68.1% | |||
| Net margin, % | ? | 56.2% | 53.6% | 53.6% | 57.1% | 57.8% | 56.7% | |||
| FCF yield, % | ? | 2.78% | 0.00% | 4.92% | 0.93% | 4.47% | 2.71% | |||
| ROE, % | ? | 9.62% | 10.0% | 10.0% | 11.9% | 12.1% | 12.2% | |||
| ROA, % | ? | 1.34% | 1.54% | 1.54% | 2.46% | 2.48% | 2.51% | |||
| P/E | ? | 31.1 | 22.4 | 22.4 | 23.8 | 23.4 | 23.0 | |||
| P/FCF | 36.0 | 20.3 | 107.4 | 22.4 | 36.9 | |||||
| P/S | ? | 17.5 | 12.0 | 12.0 | 13.6 | 13.6 | 13.0 | |||
| P/BV | ? | -21.3 | -14.9 | -14.9 | 4.66 | -19.0 | -21.8 | |||
| EV/EBITDA | ? | 29.5 | 15.1 | 19.3 | 20.1 | 20.2 | 19.6 | |||
| Debt/EBITDA | 0.18 | 0.15 | 0.20 | 0.10 | 0.23 | 0.47 | ||||
| R&D/CAPEX, % | 151.4% | 210.3% | 286.3% | 290.4% | ||||||
| CAPEX/Revenue, % | 2.71% | 0.00% | 1.79% | 0.00% | 1.37% | 0.69% | ||||
| CME shareholders | ||||||||||
